Related Experiment Video
Updated: Sep 12, 2026
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Knockdown of SALL4 Inhibits Proliferation, Migration, and Invasion in Osteosarcoma Cells
Abstract:
Sal-like protein 4 (SALL4) is a zinc finger transcription factor that has been reported to be aberrantly expressed in several human malignancies and identified as an oncogene. However, the potential role of SALL4 in osteosarcoma remains to be elucidated. In this study, we explored the biological functions of SALL4 in osteosarcoma. We found that SALL4 was overexpressed in osteosarcoma tissues and cell lines. Knockdown of SALL4 inhibited osteosarcoma cell proliferation, migration, and invasion in vitro. In addition, SALL4 knockdown suppressed osteosarcoma growth and metastasis in vivo. We also showed that SALL4 knockdown decreased the protein expression of Wnt3a and β-catenin in osteosarcoma cells. Taken together, our study showed that SALL4 plays an important role in regulating the proliferation, migration, and invasion of osteosarcoma cells. Thus, SALL4 may represent a potential therapeutic target in the treatment of osteosarcoma.
Insights
Sal-like protein 4 (SALL4) drives osteosarcoma growth and spread. Inhibiting SALL4 suppressed tumor progression and metastasis, suggesting SALL4 as a potential therapeutic target for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Sal-like protein 4 (SALL4) is implicated as an oncogene in various human cancers.
- The specific role of SALL4 in osteosarcoma pathogenesis is not well understood.
- Understanding SALL4's function is crucial for developing targeted therapies for osteosarcoma.
Purpose of the Study:
- To investigate the biological functions of SALL4 in osteosarcoma.
- To determine if SALL4 plays a role in osteosarcoma cell proliferation, migration, and invasion.
- To explore SALL4's potential as a therapeutic target in osteosarcoma treatment.
Main Methods:
- Quantitative analysis of SALL4 expression in osteosarcoma tissues and cell lines.
- In vitro studies involving SALL4 knockdown to assess effects on cell proliferation, migration, and invasion.
- In vivo experiments using mouse models to evaluate the impact of SALL4 knockdown on tumor growth and metastasis.
- Western blot analysis to examine the expression of Wnt3a and β-catenin proteins following SALL4 knockdown.
Main Results:
- SALL4 was found to be overexpressed in osteosarcoma tissues and cell lines.
- Knockdown of SALL4 significantly inhibited osteosarcoma cell proliferation, migration, and invasion in vitro.
- SALL4 knockdown suppressed tumor growth and metastasis in vivo.
- Reduced expression of Wnt3a and β-catenin was observed upon SALL4 knockdown in osteosarcoma cells.
Conclusions:
- SALL4 plays a critical role in regulating the proliferation, migration, and invasion of osteosarcoma cells.
- SALL4 influences osteosarcoma progression through the Wnt signaling pathway.
- SALL4 represents a promising therapeutic target for osteosarcoma treatment.
